An Aggressive Signet Ring Cell Carcinoma of the Prostate in a Japanese Man

Signet ring cell carcinoma (SRCC) of the prostate is rare, with approximately 100 case reports to date. Here we report a very aggressive case of SRCC of the prostate in a Japanese man. The patient received estramustine, docetaxel, and carboplatin combination chemotherapy, followed by TS-1 and CPT-11...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Yasuhiro, Imanishi, Kengo, Okamoto, Akiko, Sasaki, Atsushi, Saitoh, Hisao, Wada, Ryuichi, Yamamoto, Hayato, Koie, Takuya, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: October, 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220913/
https://www.ncbi.nlm.nih.gov/pubmed/22114579
http://dx.doi.org/10.1159/000334081
Descripción
Sumario:Signet ring cell carcinoma (SRCC) of the prostate is rare, with approximately 100 case reports to date. Here we report a very aggressive case of SRCC of the prostate in a Japanese man. The patient received estramustine, docetaxel, and carboplatin combination chemotherapy, followed by TS-1 and CPT-11 combination therapy. Unfortunately, the disease progressed, and he died of general metastatic disease treated over 16 month with systemic chemotherapy.

Ejemplares similares